Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Safinamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Safinamide intermediate offering high purity and yield improvements for pharmaceutical supply chains and cost reduction.
Novel patent CN105061245A details moderate conditions for Safinamide. Offers supply chain reliability and cost reduction in API manufacturing.
Novel reductive amination method achieves over 80% yield and 99.5% purity, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN121342678A enables one-pot synthesis for high purity Safinamide Mesylate. Reduces waste and cost for reliable pharmaceutical intermediate supply chains.